eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Share:
Share:
Original paper

Connection of vitamin D levels in blood serum with helicobacter pylori infection in paediatric patients

Kairat Rysbekov
1
,
Sagira Abdrakhmanova
1
,
Rashida Satybaeva
1
,
Dmitry Babenko
2
,
Zhanat Abdikadyr
3

  1. Department of Pediatric Diseases with Courses in Cardio-rheumatology and Gastroenterology, Astana Medical University, Astana, Kazachstan
  2. Department of Scientific and Research Center, Karaganda Medical University, Karaganda, Kazachstan
  3. Department of Biostatistics, Bioinformatics and Information Technology, Astana Medical University, Astana, Kazakhstan
Gastroenterology Rev
Online publish date: 2024/12/30
Article file
Get citation
 
PlumX metrics:
 
1. Aguilera MI, Diaz Oliva SE, Escobedo AA, et al. Helicobacter pylori infection in children. BMJ Paed Open 2020; 4: e000679.
2. Yuan C, Adeloye D, Luk TT, et al. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lan Child Adol Health 2022; 6: 185-91.
3. Zamani M, Ebrahimtabar F, Zamani V, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Alim Pharm Ther 2018; 47: 868-76.
4. Tran V, Saad T, Tesfaye M, et al. Helicobacter pylori (H. pylori) risk factor analysis and prevalence prediction: a machine learning-based approach. BMC Inf Dis 2022; 22: 655.
5. Ortiz-Princz D, Daoud G, Salgado-Sabel A, Cavazza ME. Helicobacter pylori infection in children: should it be carefully assessed? Eur Rev Med Pharm Sci 2016; 20: 1798-813.
6. James KYH, Wan YL, Wee KN, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 2017; 153: 420-9.
7. Ito M, Sugiyama A, Mino M, et al. Prevalence of Helicobacter pylori infection in the general population evaluated by a resident-register-based epidemiological study. J Gastr 2022; 57: 540-6.
8. Miller AK, Williams SM. Helicobacter pylori infection causes both protective and deleterious effects in human health and disease. Genes Immun 2021; 22: 218-26.
9. Lee YC, Maria PD, Graham DY. Diagnosis and treatment of Helicobacter pylori infection. Ann Rev Med 2022; 73: 183-93.
10. Zhaksylyk A, Nurbakyt A, Grjibovski A, et al. Epidemiology of gastrointestinal disease among children and adolescents in Kazakhstan: 2012-2019. Open Acc Maced J Med Sci 2021; 9: 1244-9.
11. Mežmale L, Polaka I, Rudzite D, et al. Prevalence and potential risk factors of Helicobacter pylori infection among asymptomatic individuals in Kazakhstan. Asian Pac J Can Prev 2021; 22: 597-602.
12. Šterbenc A, Jarc E, Poljak M, Homan M. Helicobacter pylori virulence genes. World J Gastr 2019; 25: 4870-84.
13. Mehrabani S. Helicobacter pylori infection in children: a comprehensive review. J Clin Med Maed 2019; 14: 292-7.
14. Liu DS, Wang YH, Zhu ZH, et al. Characteristics of Helicobacter pylori antibiotic resistance: data from four different populations. Anti Res Inf Cont 2019; 8: 192.
15. Savoldi A, Carrara E, Graham DY, et al. Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions. Gastroenterology 2018; 155: 1372-82.
16. Tacconelli E, Carrara E, Savoldi A. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lan Inf Dis 2018; 18: 318-27.
17. Uehara N, Yagihashi A, Kondoh K, et al. Human-defensin-2 induction in Helicobacter Hp-infected gastric mucosal tissues: antimicrobial effect of overexpression. J Med Microb 2003; 52: 41-5.
18. Pero R, Angrisano T, Brancaccio M, et al. Beta-defensins and analogs in Helicobacter pylori infections: mRNA expression levels, DNA methylation, and antibacterial activity. PLoS One 2019; 14: e0222295.
19. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1.25-dihydroxyvitamin D3. FASEB J 2005; 19: 1067-77.
20. Hu W, Zhang L, Li MX. Vitamin D3 activates the autolysosomal degradation function against Helicobacter pylori through the PDIA3 receptor in gastric epithelial cells. Autophagy 2019; 15: 707-25.
21. Wanibuchi K, Hosoda K, Ihara M, et al. Indene compounds synthetically derived from Vitamin D have selective antibacterial action on Helicobacter pylori. Lipids 2018; 53: 393-401.
22. Assaad S, Costanian C, Jaffal L, et al. Association of TLR4 polymorphisms, expression, and vitamin D with Helicobacter pylori infection. J Pers Med 2019; 9: 2.
23. Assaad S, Chaaban R, Tannous F, Costanian C. Dietary habits and Helicobacter pylori infection: a cross sectional study at a Lebanese hospital. BMC Gastr 2018; 18: 48.
24. Han C, Ni Z, Yuan T. Influence of serum vitamin D level on Helicobacter pylori eradication: a multi-center, observational, prospective and cohort study. J Diges Dis 2019; 20: 421-6.
25. Gao T, Zhao M, Zhang C, et al. Association of Helicobacter pylori infection with vitamin D deficiency in infants and toddlers. Amer J Trop Med Hyg 2020; 102: 541-6.
26. Chen LW, Chien CY, Hsieh CW, et al. The associations between Helicobacter pylori infection, serum vitamin D, and metabolic syndrome: a community-based study. Medicine 2016; 95: e3616.
27. Ikezaki H, Furusyo N, Jacques PF, et al. Higher dietary cholesterol and -3 fatty acid intakes are associated with a lower success rate of Helicobacter pylori eradication therapy in Japan. Amer J Clin Nutr 2017; 106: 581-8.
28. Płudowski P, Karczmarewicz E, Bayer M, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe – recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endok Pol 2017; 64: 319-27.
29. Shafrir A, Shauly-Aharonov M, Katz LH, et al. The association between serum vitamin D levels and Helicobacter pylori presence and eradication. Nutrients 2021; 13: 278.
30. Mut Surmeli D, Surmeli ZG, Bahsi R, et al. Vitamin D deficiency and risk of Helicobacter pylori infection in older adults: a cross-sectional study. Aging Clin Exp Res 2019; 31: 985-91.
31. Amrein K, Scherkl M, Hoffmann M, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr 2020; 74: 1498-513.
32. El Shahawy MS, Hemida MH, El Metwaly I, Shady ZM. The effect of vitamin D deficiency on eradication rates of Helicobacter pylori infection. JGH Open 2018; 2: 270-5.
33. Hu W, Zhang L, Li MX, et al. Vitamin D3 activates the autolysosomal degradation function against Helicobacter pylori through the PDIA3 receptor in gastric epithelial cells. Autophagy 2019; 15: 707-25.
34. Salem-Sokhn E, Salami A, Fawaz M, et al. Helicobacter pylori interacts with serum vitamin D to influence hypertension. Cur Aging Sci 2021; 14: 26-31.
35. Huang B, Yan S, Chen C, Ye S. Effect of 25-hydroxyvitamin D on Helicobacter pylori eradication in patients with type 2 diabetes. Wien Klin Woch 2019; 131: 75-80.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.